CIK 0000727510
- Non-accelerated filer
- Smaller reporting company
Viskase Holdings, Inc.
Sign in to watch- Ticker
- VISK
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222372868
- Phone
- +1 630-874-0700
- Business address
- 333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
- Former names
- ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-01-23 | Conover Charles SVP, R&D Program Management | Grant or award | +2,343 | 74,793 | ||
| 2012-06-05 | Conover Charles SVP, R&D Program Management | Sale | −25,000 | $6.78 | $170K | 57,213 |
| 2012-01-17 | Conover Charles SVP, R&D Program Management | Grant or award | +10,000 | 82,213 | ||
| 2012-01-17 | Conover Charles SVP, R&D Program Management | Grant or award · Employee Stock Option (Right to Buy) | +25,000 | 25,000 |
Page 1 of 1 · 4 trades